Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, offering promising progress throughout many professional medical and industrial apps. With its structural similarity to In a natural way derived human serum albumin, OsrHSA provides a safer, additional trusted substitute for therape